Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Regulation

Foundation for inclusion

How the National Kidney Foundation is driving patient-centric R&D

August 11, 2017 10:23 PM UTC

Hosting a patient-focused drug development workshop was the National Kidney Foundation Inc.’s first step in assuming the role of facilitator to collect patient perspectives that will shape R&D for kidney disease.

On Aug. 4, the advocacy group hosted a meeting of patients and caregivers, senior FDA leaders and drug company executives to discuss patient perspectives on C3 glomerulopathy (C3G). C3G is a rare condition caused by deposition of fragments of complement 3 (C3) protein in the kidneys...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article